214 related articles for article (PubMed ID: 37682775)
1. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
Ke J; Jin C; Tang J; Cao H; He S; Ding P; Jiang X; Zhao H; Cao W; Meng X; Gao F; Lan P; Li R; Wu X
Dis Colon Rectum; 2023 Dec; 66(12):e1195-e1206. PubMed ID: 37682775
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Pathologic Complete Response for Rectal Cancer Based on Pretreatment Factors Using Machine Learning.
Chen KA; Goffredo P; Butler LR; Joisa CU; Guillem JG; Gomez SM; Kapadia MR
Dis Colon Rectum; 2024 Mar; 67(3):387-397. PubMed ID: 37994445
[TBL] [Abstract][Full Text] [Related]
3. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
4. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
[TBL] [Abstract][Full Text] [Related]
5. Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer.
Deidda S; Spolverato G; Capelli G; Bao RQ; Bettoni L; Crimì F; Zorcolo L; Pucciarelli S; Restivo A
Dis Colon Rectum; 2023 Jul; 66(7):957-964. PubMed ID: 36538694
[TBL] [Abstract][Full Text] [Related]
6. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
[TBL] [Abstract][Full Text] [Related]
7. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
[TBL] [Abstract][Full Text] [Related]
9. Deep Learning-Based Model for Identifying Tumors in Endoscopic Images From Patients With Locally Advanced Rectal Cancer Treated With Total Neoadjuvant Therapy.
Thompson HM; Kim JK; Jimenez-Rodriguez RM; Garcia-Aguilar J; Veeraraghavan H
Dis Colon Rectum; 2023 Mar; 66(3):383-391. PubMed ID: 35358109
[TBL] [Abstract][Full Text] [Related]
10. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
[TBL] [Abstract][Full Text] [Related]
11. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.
Dudani S; Marginean H; Gotfrit J; Tang PA; Monzon JG; Dennis K; Kennecke HF; Powell ED; Babak S; Cheung WY; Vickers MM
Dis Colon Rectum; 2021 Dec; 64(12):1471-1478. PubMed ID: 34657078
[TBL] [Abstract][Full Text] [Related]
14. Development of a Diagnostic Artificial Intelligence Tool for Lateral Lymph Node Metastasis in Advanced Rectal Cancer.
Ozaki K; Kurose Y; Kawai K; Kobayashi H; Itabashi M; Hashiguchi Y; Miura T; Shiomi A; Harada T; Ajioka Y
Dis Colon Rectum; 2023 Dec; 66(12):e1246-e1253. PubMed ID: 37260284
[TBL] [Abstract][Full Text] [Related]
15. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
[TBL] [Abstract][Full Text] [Related]
18. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
19. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
Lim YJ; Song C; Jeon SH; Kim K; Chie EK
Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]